Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of chlorambucil and prednisone is a chemotherapy regimen used primarily for treating various types of cancer, particularly hematological malignancies. This combination leverages the complementary mechanisms of these two drugs to achieve better therapeutic outcomes than either drug alone. ## Composition and Mechanism Chlorambucil is an alkylating agent that works by forming covalent bonds with nucleic acids, disrupting DNA strands and suppressing antibody production[1][3]. It belongs to the nitrogen mustard family of chemotherapy drugs and is cell cycle non-specific, being most effective during the resting phase of cell division[4]. Prednisone is a corticosteroid with anti-inflammatory and immunosuppressive properties. When combined with chlorambucil, it enhances the overall efficacy of the treatment regimen. ## Medical Uses The chlorambucil + prednisone combination is primarily used to treat: - **Chronic lymphocytic leukemia (CLL)**[1][6] - **Non-Hodgkin's lymphoma**[2][6] - **Hodgkin's disease**[2][6] - **Waldenström's macroglobulinemia**[5] In veterinary medicine, this combination is also used to treat lymphoma, inflammatory bowel disease, and immune-mediated disorders in dogs and cats[3][4]. ## Dosage and Administration The dosage regimen varies depending on the specific condition being treated: - For Waldenström's macroglobulinemia: chlorambucil (8 mg/m² daily) and prednisone (40 mg/m² daily) for 10 days every 6 weeks[5] - For chronic lymphocytic leukemia and non-Hodgkin's lymphoma: dosages are typically adjusted based on clinical response and hematologic parameters[5] The medication is usually administered orally, with chlorambucil often taken on an empty stomach[6]. ## Side Effects Common side effects include: - Hematologic effects: lymphopenia, neutropenia, and potential bone marrow suppression[5] - Gastrointestinal symptoms: nausea, vomiting (though less severe than with some other chemotherapy regimens)[2][4] - Increased susceptibility to infections due to immunosuppression[4] More serious but less common side effects include: - Seizures (particularly with high doses)[5] - Irreversible bone marrow damage (with high cumulative doses)[5] ## Advantages Over Other Regimens The chlorambucil + prednisone combination is often preferred over more aggressive chemotherapy regimens like MOPP (mechlorethamine, vincristine, procarbazine, prednisone) because it causes less severe side effects such as nausea, vomiting, hair loss, and neuropathy, which can improve patient compliance[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorambucil + prednisone.